Philip M Hanno, MD
Urology · Stanford
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
- California licence: Delinquent
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hanno’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G139173 · Delinquent
Licence status: Delinquent · since 2015 · expires 2023-08-31 · Baylor College of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$373 in 2019
Medicaid paid $373 for 12 billed services this clinician did in 2019, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 12 | $373 |
| 2019 | 12 | 1 | 12 | $373 |
Money from drug and device companies
$1,728 in 2025
| 2025 | 1 | 1 | $1,728 | $1,728 |
| 2023 | 2 | 2 | $11,098 | $11,098 |
| 2022 | 1 | 3 | $7,398 | $7,398 |
| 2021 | 3 | 7 | $11,850 | $11,850 |
| 2020 | 1 | 1 | $1,250 | $1,250 |
| 2019 | 1 | 1 | $2,585 | $2,585 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Purdue Pharma L.P. | None | $1,728 | 1 payment
|
See the published payment
| Purdue Pharma L.P. | Consulting · 2025-09-19 | None | $1,728 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $11,098
| HRA Pharma | None | $10,000 | 1 payment
|
| Imbrium Therapeutics L.P. | None | $1,098 | 1 payment
|
2022: $7,398
| Imbrium Therapeutics L.P. | None | $7,398 | 3 payments
|
2021: $11,850
| Imbrium Therapeutics L.P. | None | $8,400 | 5 payments
|
| Shionogi | None | $2,950 | 1 payment
|
| Ironwood Pharmaceuticals | None | $500 | 1 payment
|
2020: $1,250
| Teva Pharmaceuticals USA | Ajovy | $1,250 | 1 payment
|
2019: $2,585
| Teva Pharmaceuticals USA | Ajovy | $2,585 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| SEIKAGAKU CORPORATION · 2021 | This clinician | $8,160 |
Professional record
- NPI
- 1174563175
- Licence
- CA G139173, PA MD016982ECalifornia G139173: Delinquent · expires 2023-08-31
More record details
- Sole proprietor
- No
- Medicaid ID
- PA 0007369970001
- Taxonomy
- Urology (208800000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-06-07
- NPI last updated
- 2016-08-16
This is when the NPI record was last certified, not a medical board exam.